Efficacy of Zinc Sulfate With Probiotics for the Treatment of Acute Diarrhea in Children (Zinc)
Primary Purpose
Acute Watery Diarrhoea
Status
Unknown status
Phase
Phase 2
Locations
Poland
Study Type
Interventional
Intervention
Zinc Sulfate
Sponsored by
About this trial
This is an interventional treatment trial for Acute Watery Diarrhoea focused on measuring acute diarrhoea, children
Eligibility Criteria
Inclusion Criteria:
- Age 1-36 months
- Acute diarrhea defined as 3 or more watery stools per day
- Informed consent (parents)
Exclusion Criteria:
- Severe dehydration (> 10%)
- Coexisting severe infection (e.g. sepsis, pneumonia, meningitis)
- Immune deficiency
- Chronic digestive tract disease (e.g. celiac diseases, food allergy)
- Antibiotic therapy
Sites / Locations
- Szpital im Sw Jadwigi w Trzebicy
- Klinika Pediatrii i Chorob Infekcyjnych Akademii Medycznej we Wroclawiu
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Zinc sulfate
Placebo
Arm Description
Children in active treatment group will be given zinc sulfate 10-20 mg per day orally plus probiotics
Children will be given placebo plus probiotics
Outcomes
Primary Outcome Measures
Period of diarrhea in hours
The primary endpoint of our study is the time of acute diarrhea
Secondary Outcome Measures
number of stools in consequent days
The secondary end points will be number of stools per day, necessity of hospitalization or not, tolerability and adherence to the therapy
Full Information
NCT ID
NCT01140074
First Posted
June 7, 2010
Last Updated
June 9, 2010
Sponsor
University Hospital No 1 Wroclaw
1. Study Identification
Unique Protocol Identification Number
NCT01140074
Brief Title
Efficacy of Zinc Sulfate With Probiotics for the Treatment of Acute Diarrhea in Children
Acronym
Zinc
Official Title
Effectiveness and Efficacy of Zinc With Probiotics for the Treatment of Acute Diarrhea in Young Children
Study Type
Interventional
2. Study Status
Record Verification Date
June 2010
Overall Recruitment Status
Unknown status
Study Start Date
July 2010 (undefined)
Primary Completion Date
June 2012 (Anticipated)
Study Completion Date
June 2012 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
University Hospital No 1 Wroclaw
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Diarrheal disease is one of the major causes of morbidity and mortality in children under five. Disease is treated symptomatically with oral rehydration (ORS) as a basic measure. In children with severe zinc deficiency, diarrhea is common and responds quickly to zinc supplementation. Zinc supplementation may also helpful in diarrheal children without zinc deficiency. Effectiveness of zinc was proven in developing countries but was not in Europe. Objective of our study is to assess whether zinc supplementation given with probiotics and ORS is effective in acute diarrhea in children in Poland.
Detailed Description
A double-blind, placebo controlled trial
- We are going to enroll 256 patients (aged > 1 months to 36 months) with acute watery diarrhea defined as 3 d or more watery stools per day lasting not less than 1 day and not longer than 5 days.
Exclusion criteria:
severe dehydration (> 10%) Coexisting severe infection (E.g. Sepsis, pneumonia, meningitis) Immune deficiency Chronic digestive tract disease (e.g. celiac diseases, food allergy) Therapy with Antibiotics
Patients will be randomly assigned to 2 groups to receive: (a) zinc sulfate 10-20 mg/day for 10 days plus probiotics for 5 days (b) placebo for 10 days plus probiotics for 5 days. Patients will be observed in ambulatory or in the hospital (if necessary) and followed up for 15 days.
Randomization 1:1
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Watery Diarrhoea
Keywords
acute diarrhoea, children
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Factorial Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
256 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Zinc sulfate
Arm Type
Experimental
Arm Description
Children in active treatment group will be given zinc sulfate 10-20 mg per day orally plus probiotics
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Children will be given placebo plus probiotics
Intervention Type
Drug
Intervention Name(s)
Zinc Sulfate
Other Intervention Name(s)
brand product is not available in Poland
Intervention Description
Zinc Sulfate in sugar sirup will be given orally in dosis of 10-20 mg per day for 10 days
Primary Outcome Measure Information:
Title
Period of diarrhea in hours
Description
The primary endpoint of our study is the time of acute diarrhea
Time Frame
15 days
Secondary Outcome Measure Information:
Title
number of stools in consequent days
Description
The secondary end points will be number of stools per day, necessity of hospitalization or not, tolerability and adherence to the therapy
Time Frame
15 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Month
Maximum Age & Unit of Time
36 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 1-36 months
Acute diarrhea defined as 3 or more watery stools per day
Informed consent (parents)
Exclusion Criteria:
Severe dehydration (> 10%)
Coexisting severe infection (e.g. sepsis, pneumonia, meningitis)
Immune deficiency
Chronic digestive tract disease (e.g. celiac diseases, food allergy)
Antibiotic therapy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Leszek Szenborn, Prof
Phone
++48717703151
Email
szenborn@zak.am.wroc.pl
First Name & Middle Initial & Last Name or Official Title & Degree
Ernest P. Kuchar, MD
Phone
++48717703156
Email
kuchar@zak.am.wroc.pl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Leszek Szenborn, Prof
Organizational Affiliation
Wroclaw Medical University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Szpital im Sw Jadwigi w Trzebicy
City
Trzebnica
ZIP/Postal Code
55-100
Country
Poland
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jerzy Pejcz, MD
Phone
++48713120913
First Name & Middle Initial & Last Name & Degree
Jerzy Pejcz, MD
Facility Name
Klinika Pediatrii i Chorob Infekcyjnych Akademii Medycznej we Wroclawiu
City
Wroclaw
ZIP/Postal Code
50-345
Country
Poland
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Leszek Szenborn, Prof
Phone
++48717703151
Email
szenborn@zak.am.wroc.pl
First Name & Middle Initial & Last Name & Degree
Ernest P. Kuchar, MD
Phone
++48717703156
Email
kuchar@zak.am.wroc.pl
First Name & Middle Initial & Last Name & Degree
Leszek Szenborn, Prof
12. IPD Sharing Statement
Citations:
PubMed Identifier
20374562
Citation
Larson CP, Nasrin D, Saha A, Chowdhury MI, Qadri F. The added benefit of zinc supplementation after zinc treatment of acute childhood diarrhoea: a randomized, double-blind field trial. Trop Med Int Health. 2010 Jun;15(6):754-61. doi: 10.1111/j.1365-3156.2010.02525.x. Epub 2010 Mar 29.
Results Reference
background
PubMed Identifier
19068562
Citation
Fajolu IB, Emokpae A, Oduwole AO, Silva BO, Abidoye RO, Renner JK. Zinc supplementation in children with acute diarrhoea. Nig Q J Hosp Med. 2008 Apr-Jun;18(2):101-3. doi: 10.4314/nqjhm.v18i2.44997.
Results Reference
background
PubMed Identifier
16354711
Citation
Boran P, Tokuc G, Vagas E, Oktem S, Gokduman MK. Impact of zinc supplementation in children with acute diarrhoea in Turkey. Arch Dis Child. 2006 Apr;91(4):296-9. doi: 10.1136/adc.2005.079939. Epub 2005 Dec 14.
Results Reference
background
PubMed Identifier
9370894
Citation
Roy SK, Tomkins AM, Akramuzzaman SM, Behrens RH, Haider R, Mahalanabis D, Fuchs G. Randomised controlled trial of zinc supplementation in malnourished Bangladeshi children with acute diarrhoea. Arch Dis Child. 1997 Sep;77(3):196-200. doi: 10.1136/adc.77.3.196.
Results Reference
result
Learn more about this trial
Efficacy of Zinc Sulfate With Probiotics for the Treatment of Acute Diarrhea in Children
We'll reach out to this number within 24 hrs